Cabazitaxel API is a taxane-class antineoplastic agent used in the treatment of metastatic castration-resistant prostate cancer. It inhibits microtubule disassembly, leading to cell cycle arrest and apoptosis, and is manufactured under GMP conditions for injectable formulations.

Cabazitaxel API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.